US clears Eisai's fospropofol for use by anaesthesiologists
This article was originally published in Scrip
Executive Summary
The US FDAhas approved Eisai's intravenous sedative-hypnotic agent Lusedra (fospropofol), albeit with use requirements and a brand name different from those originally proposed.